Blaine Davis

Track

Insider profile

Currently holds a position at Protara Therapeutics Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer Protara Therapeutics Inc Feb. 11, 2020 -
Blaine Davis's trades of Cartesian Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-08 2026-01-06
S Sale
76,908 +37.4%
202.36
US$4,914,782 		76,908 +37.4% 202.36 US$4,914,782
2025-01-07 2025-01-06
S Sale
18,570 +18.1%
124.60
US$1,592,456 		18,570 +18.1% 124.60 US$1,592,456
2025-01-07 2025-01-03
S Sale
19,471 +40.1%
214.26
US$1,032,306 		19,471 +40.1% 214.26 US$1,032,306
2020-09-23 2020-09-22
B Purchase
1,481 +inf%
16.91
US$25,038 		1,481 +inf% 16.91 US$25,038